TVgog56789@lemy.lolM to

US News@lemy.lolEnglish · 6 months ago

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

arstechnica.com

0

cross-posted to:
news@lemmy.world

10

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

arstechnica.com

TVgog56789@lemy.lolM to

US News@lemy.lolEnglish · 6 months ago

0

cross-posted to:
news@lemmy.world

FDA advisers will meet June 4 to discuss and vote on the therapy's effectiveness.

cross-posted from: https://reddthat.com/post/19935197

You must log in or # to comment.

Chat